This Investor Built a $56 Million Position in RAPT Last Quarter. It Was Just Acquired for $58 Per Share

OrbiMed Advisors increased its position in RAPT Therapeutics by 556,273 shares during Q4, an estimated trade size of $17.28 million based on quarterly average pricing. The transaction signals institutional accumulation and could modestly support the stock, but it is routine disclosure-level activity rather than company-specific fundamental news.

Analysis

OrbiMed Advisors increased its position in RAPT Therapeutics by 556,273 shares during Q4, an estimated trade size of $17.28 million based on quarterly average pricing. The transaction signals institutional accumulation and could modestly support the stock, but it is routine disclosure-level activity rather than company-specific fundamental news.